Accresa

Accresa is a healthcare technology company whose public site describes software for subscription care: payments, billing, provider networks, and member enrollment, including direct primary care (accresa.com). A.E. Perkins Our Brands describes it as a platform for direct primary care and subscription services.

William C. Short

LinkedIn lists him as Executive Chairman, CEO, and founder from January 2015. A.E. Perkins leadership groups Accresa with Ameriflex and Workforce Go under his current roles.

Patents

Accresa Health LLC is the assignee of two issued U.S. patents naming William C. Short as inventor.

U.S. Patent 12,682,329, Systems and method for multi-layer adaptive packet routing, issued on 14 July 2026 (patent record). It covers a computer-implemented process that brings multiple payors and healthcare payees into a configurable group, bundles invoice data, determines payment responsibility under healthcare-plan rules, collects funds, and distributes them to the appropriate providers.

U.S. Patent 12,770,120, Systems and methods for multi-layer adaptive packet routing, issued on 20 October 2026 (patent record). It covers a custom group instance of healthcare providers and user groups governed by group parameters, with claims directed to adding new patients to groups, modifying group parameters, and routing payments to healthcare providers. Its dependent claims include enrollment events triggered by data extracted from EDI 834 files.

The patents are significant to Accresa because they protect the payment-orchestration layer behind many-to-many healthcare transactions and the enrollment and plan-change events that drive it. That layer can replace numerous disconnected invoices and payments with rules-based allocation, consolidated billing, and provider settlement. It is relevant to direct primary care, direct-to-employer care, subscription medicine, and other models involving recurring payments among employers, members, plans, administrators, and providers.

VentureBeat reported the grant of US 12,682,329 and quoted Short as CEO of Accresa. Both issued patents followed a continuation family dating to 2018. See Patents for the claim groups, filing chronology, and limits of the patents' significance.